| For: | Liu JY, Gao DL, Cao X. Risk factors and diagnostic biomarkers for asymptomatic immune checkpoint inhibitor-related myocarditis in patients with esophageal cancer after immunotherapy. World J Gastroenterol 2025; 31(26): 106509 [PMID: 40678710 DOI: 10.3748/wjg.v31.i26.106509] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i26/106509.htm |
| Number | Citing Articles |
| 1 |
Zhenli Li, Yingjie Guo, Tenghui Wang, Tiezhu Yao, Jingtao Ma. Prognostic role of the Prognostic Nutritional Index in immune checkpoint inhibitor-related myocarditis for upper gastrointestinal tract cancers ‒ A retrospective clinical study. Nutrición Hospitalaria 2026; doi: 10.20960/nh.06808
|
| 2 |
Tushar Bhadra, Brandon Lucke-Wold. Risk elements and diagnostic indicators for asymptomatic immune checkpoint inhibitor-associated myocarditis in esophageal cancer. World Journal of Gastroenterology 2025; 31(44): 113689 doi: 10.3748/wjg.v31.i44.113689
|
| 3 |
Udochukwu Godswill Anosike, Roy Olunga, Emmanuel Korir, Sonia Ijeoma Etumudon, Christine Brezden-Masley, Elliot Wakeam, Jelena Lukovic, Michael Yan, Amna Zafar, Husam Abdel-Qadir. Resectable Esophageal Cancer Therapy-Related Cardiac Dysfunction: A Review of Mechanisms and Predictive Tools. Foregut: The Journal of the American Foregut Society 2026; doi: 10.1177/26345161261473791
|
| 4 |
Bihan Sun, Song Guo. Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity. Frontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1891563
|